Skip to main content
. 2017 Sep 22;12(9):e0184625. doi: 10.1371/journal.pone.0184625

Fig 1. LAT1 immunolabelling (x400).

Fig 1

Diffuse and strong LAT1 expression in a small cell glioblastoma (a) and in a metastasis of ovary adenocarcinoma (b). Weak LAT1 expression in a glioblastoma (c) and in a metastasis of lung adenocarcinoma (d). Note LAT1 expression in endothelial cells (c).